Clarus Therapeutics Holdings, Inc.
CRXTDelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817944
Clarus Therapeutics Holdings, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Jun 9, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.82M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Clarus Therapeutics Holdings, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 12 | 13 | +1 |
| Shares | 4.30M | 2.50M | −1.80M (−41.8%) |
| Value | $10.5M | $3.73M | −$6.73M (−64.3%) |
New holders (7)
Institutions that held Clarus Therapeutics Holdings, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 90,000 | $134.0K | 0.00% |
| Millennium Management LLC | 39,228 | $58.0K | 0.00% |
| Renaissance Technologies LLC | 34,700 | $52.0K | 0.00% |
| Geode Capital Management, LLC | 33,915 | $50.0K | 0.00% |
| Virtu Financial LLC | 20,353 | $30.0K | 0.00% |
| Citigroup Inc | 7,400 | $11.0K | 0.00% |
| Royal Bank of Canada | 500 | $1.00K | 0.00% |
Sold out (6)
Institutions that held Clarus Therapeutics Holdings, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Armistice Capital, LLC | 1,929,876 | $4.69M |
| Powell Investment Advisors, LLC | 64,000 | $156.0K |
| Schonfeld Strategic Advisors LLC | 20,800 | $51.0K |
| Tudor Investment Corp Et Al | 18,148 | $44.0K |
| Citadel Advisors LLC | 12,597 | $31.0K |
| Morgan Stanley | 2 | $0 |